• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.

作者信息

Lucas B Daniel

机构信息

Centers for Clinical Sciences Research, Charleston Area Medical Center Health Education and Research Institute, 3200 Mac-Corkle Avenue, S.E., Charleston, WV 25304-1200, USA.

出版信息

Am J Health Syst Pharm. 2002 Nov 1;59(21):2101-3. doi: 10.1093/ajhp/59.21.2101.

DOI:10.1093/ajhp/59.21.2101
PMID:12434726
Abstract
摘要

相似文献

1
Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.冠状动脉搭桥术后的降脂治疗：是时候采取更积极的干预措施了。
Am J Health Syst Pharm. 2002 Nov 1;59(21):2101-3. doi: 10.1093/ajhp/59.21.2101.
2
Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.药学咨询对接受冠状动脉血运重建术患者联合降脂治疗依从性和有效性的影响：一项随机对照试验。
Pharmacotherapy. 2000 Apr;20(4):410-6. doi: 10.1592/phco.20.5.410.35048.
3
A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting.冠状动脉搭桥术后低剂量联合降脂治疗的随机对照试验。
Clin Cardiol. 1994 Feb;17(2):59-64. doi: 10.1002/clc.4960170204.
4
Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints.
Cardiovasc Drugs Ther. 2000 Aug;14(4):411-8. doi: 10.1023/a:1007816300468.
5
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.载脂蛋白B水平高的男性强化降脂治疗后冠状动脉疾病的消退
N Engl J Med. 1990 Nov 8;323(19):1289-98. doi: 10.1056/NEJM199011083231901.
6
Aggressive lipid-lowering therapy beneficial after bypass grafting, say researchers.研究人员称，积极的降脂治疗在冠状动脉搭桥术后有益。
Am J Health Syst Pharm. 1997 Mar 15;54(6):626. doi: 10.1093/ajhp/54.6.626a.
7
Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B.强化降脂治疗对载脂蛋白B升高的无症状受试者冠状动脉的影响。
Circulation. 1993 Dec;88(6):2744-53. doi: 10.1161/01.cir.88.6.2744.
8
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy.基因决定的载脂蛋白B水平和低密度脂蛋白峰值密度可预测强化降脂治疗的血管造影反应。
J Intern Med. 2006 Apr;259(4):401-9. doi: 10.1111/j.1365-2796.2006.01626.x.
9
Treatment of the patient with primary familial heterozygous hypercholesterolemia.原发性家族性杂合子高胆固醇血症患者的治疗。
J Cardiovasc Nurs. 1995 Jan;9(2):80-6. doi: 10.1097/00005082-199501000-00008.
10
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Int J Artif Organs. 1995 Dec;18(12):786-93.